BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Omni Bio Pharmaceutical 

700 17th Street
Suite 1200
Denver  Colorado  80202  U.S.A.
Phone: 303-893-1003 Fax: n/a


SEARCH JOBS










 Company News
Omni Bio Pharmaceutical To Present At 7th Annual BioPharm America Conference 9/18/2014 1:59:01 PM
Omni Bio Pharmaceutical Appoints Jack Riccardi As Chief Financial Officer 8/14/2014 1:32:10 PM
Omni Bio Pharmaceutical Announces Grant Of New Use Patent In Europe 5/8/2014 8:53:44 AM
Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest To Chief Development Officer Role 5/1/2014 10:00:15 AM
Omni Bio Pharmaceutical Announces Publication Of Its Pilot Study Of Alpha-1 Antitrypsin In Type 1 Diabetes 4/30/2014 11:11:50 AM
Gallus Biopharmaceuticals, LLC Enters Cell Line Optimization And Manufacturing Agreement With Omni Bio Pharmaceutical 4/29/2014 11:17:54 AM
Omni Bio Pharmaceutical Announces $3 Million Private Financing Plan And New Investment Banking Services Advisor 4/25/2014 8:47:48 AM
Omni Bio Pharmaceutical Announces Notice Of Allowance For New Use Patent 11/26/2013 10:11:53 AM
Omni Bio Pharmaceutical Announces Reduction in Inflammatory Myocardial Injury With Its Lead Recombinant Molecule 11/21/2013 11:04:34 AM
Omni Bio Pharmaceutical Announces U.S. Patent Action for Its Recombinant Alpha-1 Antitrypsin Molecule 11/6/2013 10:01:26 AM
1234